Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism AMPK modulators(AMP activated protein kinase modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H16ClNO2 |
InChIKeyGJYRCHPTBGWUDC-UHFFFAOYSA-N |
CAS Registry2819779-32-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Triple Negative Breast Cancer | Preclinical | CN | 05 Oct 2021 |